Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PLXProtalix BioTherapeutics, Inc.

NYSE · CIK 0001006281
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts301

Identity from submissions API

NameProtalix BioTherapeutics, Inc.
CIK0001006281
TickersPLX
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN650643773
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone201-696-9345
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ORTHODONTIX INC (1998-04-22T04:00:00.000Z → 2007-02-22T05:00:00.000Z)
  • EMBASSY ACQUISITION CORP (1996-08-13T04:00:00.000Z → 1998-03-31T05:00:00.000Z)
Business address
2 UNIVERSITY PLAZA
SUITE 100
HACKENSACK
NJ
07601
NJ
Mailing address
2 UNIVERSITY PLAZA
SUITE 100
HACKENSACK
NJ
07601
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

974 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001104659-26-124771 001-33357 261537894 34 4924026 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001104659-26-124761 001-33357 261537860 34 403462 1 1
2026-10-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002086358-26-000006 005-50118 261461469 34 7129
2026-09-09 4 xslF345X06/ownership.xml 0001178913-26-004471 14767
2026-09-04 4 xslF345X06/form4-09042026_060917.xml 0001742727-26-000002 14020
2026-09-04 4 xslF345X06/form4-09042026_060913.xml 0002075661-26-000002 13391
2026-09-04 4 xslF345X06/form4-09042026_060915.xml 0001614890-26-000002 13880
2026-09-04 4 xslF345X06/form4-09042026_060910.xml 0001454771-26-000002 13859
2026-09-04 4 xslF345X06/form4-09042026_060904.xml 0001781450-26-000002 13917
2026-09-04 4 xslF345X06/form4-09042026_060907.xml 0001385113-26-000002 13880
2026-09-04 4 xslF345X06/form4-09042026_060909.xml 0001935668-26-000002 14242
2026-09-04 4 xslF345X06/form4-09042026_060901.xml 0001831558-26-000003 13621
2026-08-12 S-8 FORM S-8 0001104659-26-094487 333-298249 261265351 33 242817 1 1
2026-08-12 10-Q 10-Q 0001104659-26-094444 001-33357 261265297 34 4617175 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001104659-26-094433 001-33357 261265267 34 394427 1 1
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002863 005-50118 261216958 34 11039
2026-06-25 8-K 8-K 5.07,9.01 0001104659-26-077790 001-33357 261122326 34 380053 1 1
2026-05-21 8-K 8-K 7.01,9.01 0001104659-26-064850 001-33357 261005863 34 4641498 1 1
2026-05-13 10-Q 10-Q 0001104659-26-059756 001-33357 26970891 34 3679905 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001104659-26-059749 001-33357 26970850 34 373657 1 1
2026-04-30 ARS ARS 0001104659-26-053038 001-33357 26926290 34 1606968
2026-04-30 DEF 14A DEF 14A 0001104659-26-053016 001-33357 26926129 34 3618264 1 1
2026-04-27 3/A xslF345X06/form3a-04272026_090417.xml 0001975896-26-000003 6115
2026-03-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001426156-26-000006 005-50118 26813297 34 12062
2026-03-18 10-K 10-K 0001104659-26-029858 001-33357 26765222 34 11632079 1 1
2026-03-18 8-K 8-K 2.02,9.01 0001104659-26-029846 001-33357 26765100 34 393161 1 1
2026-03-09 8-K 8-K 8.01,9.01 0001104659-26-024975 001-33357 26733219 34 229357 1 1
2026-03-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001426156-26-000002 005-50118 26722149 34 11728
2026-02-11 8-K 8-K 7.01,9.01 0001104659-26-013498 001-33357 26621943 34 4803092 1 1
2026-01-30 8-K FORM 8-K 8.01,9.01 0001104659-26-008410 001-33357 26580916 34 245843 1 1
2026-01-05 8-K 8-K 7.01,9.01 0001104659-26-000393 001-33357 26503866 34 217807 1 1
2025-12-23 4 xslF345X05/form4-12232025_121255.xml 0001781450-25-000005 10705
2025-11-19 4 xslF345X05/form4-11192025_091151.xml 0001385113-25-000005 5918
2025-11-13 10-Q 10-Q 0001104659-25-110824 001-33357 251475310 34 6493059 1 1
2025-11-13 8-K 8-K 2.02,9.01 0001104659-25-110821 001-33357 251475305 34 389810 1 1
2025-11-03 8-K 8-K 8.01,9.01 0001104659-25-105594 001-33357 251444821 34 213442 1 1
2025-10-17 8-K 8-K 7.01,8.01,9.01 0001104659-25-100264 001-33357 251399010 34 4391512 1 1
2025-09-04 4 xslF345X05/form4-09042025_050917.xml 0001415889-25-023708 7782
2025-09-04 4 xslF345X05/form4-09042025_050913.xml 0001415889-25-023706 8296
2025-09-04 4 xslF345X05/form4-09042025_050911.xml 0001415889-25-023705 8961
2025-09-04 4 xslF345X05/form4-09042025_050915.xml 0001415889-25-023707 7722
2025-09-04 4 xslF345X05/form4-09042025_050909.xml 0001415889-25-023704 8978
2025-09-04 4 xslF345X05/form4-09042025_050907.xml 0001415889-25-023703 8347
2025-09-04 4 xslF345X05/form4-09042025_050905.xml 0001415889-25-023702 9090
2025-09-04 4 xslF345X05/form4-09042025_050903.xml 0001415889-25-023701 9401
2025-09-04 4 xslF345X05/form4-09042025_050901.xml 0001415889-25-023700 9103
2025-08-25 3 xslF345X02/form3-08252025_080839.xml 0001415889-25-022924 4795
2025-08-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002712 333-286802 251247791 33 1982
2025-08-22 8-K FORM 8-K 1.01,9.01 0001104659-25-081924 001-33357 251246804 34 234635 1 1
2025-08-22 424B5 424B5 0001104659-25-081913 333-286802 251246695 33 371052
2025-08-20 CORRESP filename1.htm 0001104659-25-080754 15371
2025-08-14 S-3/A S-3/A 0001104659-25-078076 333-286802 251214273 33 49444
2025-08-14 10-Q 10-Q 0001558370-25-011471 001-33357 251214253 34 5169653 1 1
2025-08-14 8-K 8-K 2.02,9.01 0001558370-25-011468 001-33357 251214203 34 383860 1 1
2025-08-12 4 xslF345X05/form4-08122025_040801.xml 0001415889-25-021494 5392
2025-08-01 8-K 8-K 8.01 0001558370-25-009989 001-33357 251176591 34 149553 1 1
2025-07-21 8-K 8-K 1.01,5.02,9.01 0001558370-25-009308 001-33357 251135939 34 285034 1 1
2025-07-03 3 xslF345X02/form3-07032025_080709.xml 0001415889-25-019329 8188
2025-06-26 8-K 8-K 5.07 0001558370-25-008922 001-33357 251080812 34 167572 1 1
2025-05-09 10-Q 10-Q 0001558370-25-007063 001-33357 25928332 34 4424971 1 1
2025-05-09 8-K 8-K 2.02,9.01 0001558370-25-007060 001-33357 25928302 34 320638 1 1
2025-05-08 ARS ARS 0001558370-25-006992 001-33357 25926755 34 1733070
2025-04-30 DEF 14A DEF 14A 0001558370-25-006010 001-33357 25895942 34 3167740 1 1
2025-04-30 UPLOAD filename1.pdf 0000000000-25-004560 333-286802 40363
2025-04-28 S-3 FORM S-3 0001104659-25-040270 333-286802 25881372 33 1097502
2025-04-23 8-K 8-K 5.02,9.01 0001558370-25-005275 001-33357 25862007 34 160468 1 1
2025-03-17 8-K 8-K 1.01,8.01,9.01 0001558370-25-003143 001-33357 25745652 34 226433 1 1
2025-03-17 424B5 424B5 0001104659-25-024457 333-264394 25745043 33 410825
2025-03-17 10-K 10-K 0001558370-25-003039 001-33357 25742338 34 10516382 1 1
2025-03-17 8-K 8-K 2.02,9.01 0001558370-25-003036 001-33357 25742305 34 378528 1 1
2024-12-31 8-K 8-K 3.03,5.03,9.01 0001558370-24-016505 001-33357 241593356 34 373695 1 1
2024-12-23 8-K 8-K 7.01,9.01 0001558370-24-016445 001-33357 241569804 34 198275 1 1
2024-11-14 10-Q 10-Q 0001558370-24-015612 001-33357 241457125 34 4864185 1 1
2024-11-14 8-K 8-K 2.02,9.01 0001558370-24-015608 001-33357 241457040 34 394603 1 1
2024-11-05 4/A xslF345X05/form4a-11052024_051110.xml 0001415889-24-026168 5746
2024-10-25 SC 13G/A sayw24111406_13ga.htm 0000905148-24-002838 005-50118 241397348 34 96998
2024-10-25 8-K 8-K 7.01,9.01 0001558370-24-013664 001-33357 241394359 34 188041 1 1
2024-09-24 4 xslF345X05/form4-09242024_050905.xml 0001415889-24-023907 5399
2024-09-24 4 xslF345X05/form4-09242024_050902.xml 0001415889-24-023906 6499
2024-08-14 10-Q 10-Q 0001558370-24-012134 001-33357 241204094 34 5000196 1 1
2024-08-14 8-K 8-K 2.02,9.01 0001558370-24-012133 001-33357 241204056 34 396953 1 1
2024-07-01 S-8 FORM S-8 0001104659-24-076885 333-280644 241091575 33 106435
2024-06-28 8-K 8-K 5.07,9.01 0001558370-24-009567 001-33357 241080634 34 869696 1 1
2024-05-17 ARS ARS 0001558370-24-008425 001-33357 24961170 34 2631297
2024-05-17 DEFA14A DEFA14A 0001104659-24-063080 001-33357 24961069 34 32562
2024-05-10 10-Q 10-Q 0001558370-24-007695 001-33357 24932878 34 4574232 1 1
2024-05-10 8-K 8-K 2.02,9.01 0001558370-24-007692 001-33357 24932825 34 452220 1 1
2024-04-29 DEF 14A DEF 14A 0001104659-24-054084 001-33357 24891458 34 1478849
2024-04-03 4 xslF345X05/form4-04032024_050412.xml 0001415889-24-010099 6067
2024-03-14 10-K 10-K 0001558370-24-003161 001-33357 24747895 34 10122213 1 1
2024-03-14 8-K 8-K 2.02,9.01 0001558370-24-003160 001-33357 24747878 34 469704 1 1
2024-01-02 SC 13G/A SC 13G/A 0001178913-24-000004 005-50118 24500149 34 97700
2023-12-26 8-K 8-K 7.01,9.01 0001558370-23-020006 001-33357 231511306 34 289613 1 1
2023-11-06 10-Q 10-Q 0001558370-23-017664 001-33357 231378143 34 5356785 1 1
2023-11-06 8-K 8-K 2.02,9.01 0001558370-23-017657 001-33357 231378109 34 492548 1 1
2023-10-20 4 xslF345X05/form4-10202023_061001.xml 0001415889-23-014454 6209
2023-10-03 4 xslF345X05/form4-10032023_051035.xml 0001415889-23-013903 6171
2023-10-03 4 xslF345X05/form4-10032023_051032.xml 0001415889-23-013902 6183
2023-10-03 4 xslF345X05/form4-10032023_051025.xml 0001415889-23-013901 6187
2023-10-03 4 xslF345X05/form4-10032023_051016.xml 0001415889-23-013899 6236
2023-10-03 4 xslF345X05/form4-10032023_051021.xml 0001415889-23-013900 6187
2023-09-15 4 OWNERSHIP DOCUMENT 0001104659-23-101237 5802
2023-09-15 3 OWNERSHIP DOCUMENT 0001104659-23-101236 8477
2023-09-12 8-K 8-K 5.02,9.01 0001558370-23-015635 001-33357 231248978 34 305182 1 1
2023-08-17 4 OWNERSHIP DOCUMENT 0001104659-23-093073 6313
2023-08-17 4 OWNERSHIP DOCUMENT 0001104659-23-093070 5690
2023-08-17 4 OWNERSHIP DOCUMENT 0001104659-23-093069 8583
2023-08-17 4 OWNERSHIP DOCUMENT 0001104659-23-093066 6228
2023-08-11 S-8 FORM S-8 0001104659-23-090519 333-273936 231164605 33 121571
2023-08-07 10-Q 10-Q 0001558370-23-013483 001-33357 231145557 34 5227371 1 1
2023-08-07 8-K 8-K 2.02,9.01 0001558370-23-013481 001-33357 231145551 34 505468 1 1
2023-07-13 8-K 8-K 5.07 0001558370-23-011868 001-33357 231087149 34 247661 1 1
2023-07-07 424B3 424B3 0001104659-23-079143 333-237736 231077123 33 23570
2023-06-29 8-K 8-K 5.07,9.01 0001558370-23-011550 001-33357 231054308 34 282526 1 1
2023-06-28 DEFA14A DEFA14A 0001104659-23-075821 001-33357 231052602 34 24157
2023-05-30 8-K 8-K 7.01,9.01 0001558370-23-010565 001-33357 23971388 34 198200 1 1
2023-05-19 ARS ARS 0001558370-23-010262 001-33357 23941180 34 2970928
2023-05-18 DEF 14A DEF 14A 0001104659-23-062301 001-33357 23936914 34 2330778
2023-05-18 8-K 8-K 2.02,8.01,9.01 0001558370-23-010154 001-33357 23933666 34 198824 1 1
2023-05-10 8-K 8-K 8.01,9.01 0001558370-23-008953 001-33357 23904218 34 260504 1 1
2023-05-05 8-K 8-K 8.01,9.01 0001558370-23-008188 001-33357 23891161 34 249539 1 1
2023-05-04 10-Q 10-Q 0001558370-23-008132 001-33357 23889286 34 3556726 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001558370-23-007978 001-33357 23886525 34 347675 1 1
2023-05-02 PRE 14A PRE 14A 0001104659-23-054819 001-33357 23876715 34 1153832
2023-05-01 10-K/A 10-K/A 0001558370-23-007386 001-33357 23869848 34 714497 1 1
2023-02-27 424B5 424B5 0001104659-23-025650 333-264394 23670087 33 421312
2023-02-27 8-K 8-K 1.01,8.01,9.01 0001558370-23-002104 001-33357 23669989 34 534524 1 1
2023-02-27 10-K 10-K 0001558370-23-002102 001-33357 23669985 34 8669084 1 1
2023-02-27 8-K 8-K 2.02,9.01 0001558370-23-002100 001-33357 23669974 34 363834 1 1
2023-02-24 8-K 8-K 8.01,9.01 0001558370-23-001975 001-33357 23662764 34 228284 1 1
2023-01-05 4 OWNERSHIP DOCUMENT 0001104659-23-001495 5254
2023-01-03 8-K 8-K 7.01,9.01 0001558370-23-000003 001-33357 23500164 34 195658 1 1
2023-01-03 SC 13G/A SC 13G/A 0001178913-23-000004 005-50118 23500032 34 99751
2022-12-27 8-K 8-K 8.01,9.01 0001558370-22-018990 001-33357 221490583 34 162815 1 1
2022-12-21 8-K 8-K 8.01,9.01 0001558370-22-018894 001-33357 221478840 34 184011 1 1
2022-11-14 10-Q 10-Q 0001558370-22-017554 001-33357 221380125 34 4990558 1 1
2022-11-14 8-K 8-K 2.02,8.01,9.01 0001558370-22-017549 001-33357 221380090 34 444853 1 1
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098956 6077
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098953 6282
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098951 6017
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098950 6036
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098949 5999
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098948 6027
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098947 6065
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098945 6026
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098944 6022
2022-09-09 4 OWNERSHIP DOCUMENT 0001104659-22-098941 6010
2022-09-01 8-K 8-K 1.01,9.01 0001558370-22-014127 001-33357 221221310 34 162497 1 1
2022-08-15 10-Q 10-Q 0001558370-22-013560 001-33357 221162288 34 4127230 1 1
2022-08-15 8-K 8-K 2.02,9.01 0001558370-22-013557 001-33357 221162275 34 372998 1 1
2022-07-14 S-8 FORM S-8 0001104659-22-079877 333-266131 221083343 33 247557
2022-07-05 4 OWNERSHIP DOCUMENT 0001104659-22-077380 5854
2022-07-05 3 OWNERSHIP DOCUMENT 0001104659-22-077371 8426
2022-06-30 8-K 8-K 5.02,5.07,8.01,9.01 0001558370-22-010491 001-33357 221058714 34 246055 1 1
2022-06-30 UPLOAD filename1.pdf 0000000000-22-007032 39883
2022-06-29 CORRESP filename1.htm 0001104659-22-075759 29575
2022-06-23 UPLOAD filename1.pdf 0000000000-22-006794 44167
2022-06-16 DEFA14A DEFA14A 0001104659-22-071939 001-33357 221020997 34 17103
2022-06-09 SC 13G SC 13G 0001140361-22-022449 005-50118 221005696 34 90803
2022-05-26 8-K 8-K 7.01,9.01 0001558370-22-009406 001-33357 22970762 34 181814 1 1
2022-05-16 10-Q 10-Q 0001558370-22-008847 001-33357 22925401 34 3584301 1 1
2022-05-16 8-K 8-K 2.02,9.01 0001558370-22-008843 001-33357 22925366 34 346881 1 1
2022-05-02 8-K 8-K 1.01,9.01 0001558370-22-006566 001-33357 22879278 34 222780 1 1
2022-05-02 424B5 424B5 0001104659-22-053985 333-264394 22879219 33 413695
2022-04-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-29 17:00:00 9999999995-22-001214 333-264394 22879174 33 1939
2022-04-29 DEF 14A DEF 14A 0001104659-22-053664 001-33357 22876348 34 1982432
2022-04-27 CORRESP filename1.htm 0001104659-22-050904 12168
2022-04-25 UPLOAD filename1.pdf 0000000000-22-004399 40410
2022-04-20 S-3 FORM S-3 0001104659-22-047864 333-264394 22838683 33 1123773
2022-04-14 PRE 14A PRE 14A 0001104659-22-046052 001-33357 22827652 34 860926
2022-04-13 4 OWNERSHIP DOCUMENT 0001104659-22-045488 6049
2022-04-04 8-K 8-K 8.01,9.01 0001558370-22-005043 001-33357 22800353 34 229605 1 1
2022-03-31 10-K 10-K 0001558370-22-004823 001-33357 22789107 34 9429875 1 1
2022-03-31 8-K 8-K 2.02,9.01 0001558370-22-004821 001-33357 22789083 34 361132 1 1
2022-02-28 4 OWNERSHIP DOCUMENT 0001104659-22-028159 5387
2022-02-28 4 OWNERSHIP DOCUMENT 0001104659-22-028157 5355
2022-02-24 8-K 8-K 8.01,9.01 0001558370-22-001858 001-33357 22666852 34 369032 1 1
2022-02-14 SC 13G/A PROTALIX BIOTHERAPEUTICS, INC. 0000902664-22-001698 005-50118 22630303 34 51947
2022-02-11 SC 13G/A PROTALIX BIOTHERAPEUTICS, INC. 0000902664-22-001505 005-50118 22616879 34 50678
2022-01-31 SC 13G/A SC 13G/A 0001178913-22-000265 005-50118 22571299 34 99802
2021-12-22 8-K 8-K 7.01,9.01 0001558370-21-016986 001-33357 211510990 34 198986 1 1
2021-11-24 8-K 8-K 5.07 0001558370-21-016327 001-33357 211447231 34 159005 1 1
2021-11-15 10-Q 10-Q 0001558370-21-015862 001-33357 211406300 34 4334286 1 1
2021-11-15 8-K 8-K 2.02,9.01 0001558370-21-015857 001-33357 211406258 34 401154 1 1
2021-11-09 DEFA14A DEFA14A 0001104659-21-136301 001-33357 211392707 34 1368112
2021-10-12 8-K 8-K 8.01,9.01 0001558370-21-013109 001-33357 211316592 34 371544 1 1
2021-09-30 DEF 14A DEF 14A 0001558370-21-012901 001-33357 211295401 34 368857
2021-09-17 PRE 14A PRE 14A 0001558370-21-012601 001-33357 211261134 34 368850
2021-08-26 8-K 8-K 1.01,2.03,3.02,9.01 0001558370-21-012078 001-33357 211208817 34 2707245 1 1
2021-08-16 10-Q 10-Q 0001558370-21-011752 001-33357 211174485 34 3636378 1 1
2021-08-16 8-K 8-K 2.02,9.01 0001558370-21-011750 001-33357 211174464 34 461637 1 1
2021-08-13 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001558370-21-011566 001-33357 211169693 34 377752 1 1
2021-07-30 SC 13G/A SCHEDULE 13G/A 0001437749-21-017958 005-50118 211129898 34 53929
2021-07-07 8-K 8-K 5.07 0001558370-21-008801 001-33357 211077773 34 174193 1 1
2021-07-02 424B5 424B5 0001104659-21-088991 333-230604 211071404 33 400702
2021-07-02 8-K FORM 8-K 1.01,1.02,8.01,9.01 0001104659-21-088982 001-33357 211071297 34 546282 1 1
2021-07-02 424B5 424B5 0001104659-21-088964 333-230604 211071150 33 13998
2021-06-30 8-K 8-K 8.01,9.01 0001558370-21-008725 001-33357 211062867 34 164992 1 1
2021-06-15 SC 13G/A SC 13G/A 0001104659-21-081244 005-50118 211017063 34 50110
2021-06-04 DEF 14A DEF 14A 0001558370-21-008019 001-33357 21996887 34 746225
2021-06-03 4 OWNERSHIP DOCUMENT 0001104659-21-076488 9072
2021-06-02 8-K 8-K 8.01,9.01 0001558370-21-007920 001-33357 21987654 34 214905 1 1
2021-05-14 10-Q 10-Q 0001558370-21-007157 001-33357 21921912 34 4204275 1 1
2021-05-14 8-K 8-K 2.02,9.01 0001558370-21-007154 001-33357 21921890 34 401796 1 1
2021-04-30 10-K/A 10-K/A 0001558370-21-005321 001-33357 21873659 34 627478 1 1
2021-04-28 8-K 8-K 8.01,9.01 0001558370-21-004976 001-33357 21861178 34 208706 1 1
2021-03-30 10-K 10-K 0001558370-21-003681 001-33357 21783644 34 9583444 1 1
2021-03-30 8-K 8-K 2.02,9.01 0001558370-21-003678 001-33357 21783589 34 416938 1 1
2021-02-23 8-K 8-K 8.01,9.01 0001558370-21-001407 001-33357 21663022 34 208798 1 1
2021-02-16 3 OWNERSHIP DOCUMENT 0001104659-21-023428 6869
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023425 005-50118 21634750 34 50002
2021-02-16 SC 13G/A AMENDMENT NO. 5 TO SCHEDULE 13G 0001213900-21-009319 005-50118 21633765 34 31412
2021-02-16 424B5 424B5 0001104659-21-022557 333-230604 21632015 33 443741
2021-02-16 8-K FORM 8-K 1.01,2.02,8.01,9.01 0001104659-21-022556 001-33357 21632003 34 548001 1 1
2021-02-12 SC 13G SCHEDULE 13G 0001437749-21-002709 005-50118 21624580 34 80435
2021-02-11 424B5 424B5 0001104659-21-020787 333-230604 21620690 33 442935
2021-02-09 SC 13G/A PROTALIX BIOTHERAPEUTICS, INC. 0000902664-21-001018 005-50118 21603996 34 74509
2021-02-08 SC 13G/A SC 13G/A 0001140361-21-003704 005-50118 21600149 34 153384
2021-02-08 SC 13G/A SC 13G 0001178913-21-000356 005-50118 21598409 34 101141
2020-12-30 8-K 8-K 7.01,9.01 0001558370-20-014567 001-33357 201424004 34 190072 1 1
2020-11-24 SC 13G SC 13G 0001178913-20-003242 005-50118 201339808 34 55365
2020-10-29 10-Q 10-Q 0001558370-20-011974 001-33357 201270522 34 3453408 1 1
2020-10-29 8-K 8-K 2.02,9.01 0001558370-20-011970 001-33357 201270482 34 420264 1 1
2020-10-23 8-K/A 8-K/A 5.07 0001558370-20-011697 001-33357 201258346 34 155121 1 1
2020-10-01 8-K FORM 8-K 1.01,9.01 0001104659-20-111165 001-33357 201217149 34 503681 1 1
2020-10-01 424B5 424B5 0001104659-20-111156 333-230604 201217067 33 363250
2020-09-08 8-K FORM 8-K 8.01,9.01 0001104659-20-102834 001-33357 201162984 34 231097 1 1
2020-08-14 4/A FORM 4/A 0001104659-20-095626 6158
2020-08-14 4/A FORM 4/A 0001104659-20-095623 6053
2020-08-13 4 OWNERSHIP DOCUMENT 0001104659-20-094755 5691
2020-08-13 4 OWNERSHIP DOCUMENT 0001104659-20-094753 5659
2020-08-13 4 OWNERSHIP DOCUMENT 0001104659-20-094751 11211
2020-08-11 8-K FORM 8-K 8.01,9.01 0001104659-20-092996 001-33357 201091025 34 261538 1 1
2020-08-10 10-Q FORM 10-Q 0001104659-20-092375 001-33357 201087036 34 3547694 1 1
2020-08-10 8-K FORM 8-K 2.02,9.01 0001104659-20-092367 001-33357 201087017 34 118611
2020-07-08 4 OWNERSHIP DOCUMENT 0001104659-20-082116 5766
2020-07-08 3 OWNERSHIP DOCUMENT 0001104659-20-082114 8035
2020-06-11 S-8 FORM S-8 0001104659-20-072466 333-239101 20957821 33 100190
2020-06-08 4 OWNERSHIP DOCUMENT 0001104659-20-070906 11424
2020-06-08 8-K FORM 8-K 1.01,5.02,5.07,9.01 0001104659-20-070904 001-33357 20949759 34 230632
2020-06-01 10-Q/A FORM 10-Q/A 0001104659-20-068485 001-33357 20934635 34 41658
2020-06-01 10-Q FORM 10-Q 0001104659-20-067982 001-33357 20930894 34 1847555 1
2020-06-01 8-K FORM 8-K 2.02,9.01 0001104659-20-067973 001-33357 20930874 34 107596
2020-05-28 8-K FORM 8-K 8.01,9.01 0001104659-20-066624 001-33357 20916893 34 47348
2020-05-11 8-K 8-K 8.01,9.01 0001104659-20-059085 001-33357 20862542 34 43688
2020-05-11 8-K FORM 8-K 8.01 0001104659-20-059038 001-33357 20862446 34 25768
2020-04-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-04-29 16:30:00 9999999995-20-000909 333-237736 20832941 33 1949
2020-04-29 424B3 424B3 0001104659-20-053547 333-237736 20831614 33 126510
2020-04-27 CORRESP filename1.htm 0001104659-20-051570 12309
2020-04-22 UPLOAD filename1.pdf 0000000000-20-003470 40154
2020-04-17 S-3 FORM S-3 0001104659-20-048223 333-237736 20800120 33 226075
2020-04-15 DEF 14A DEF 14A 0001104659-20-046926 001-33357 20794035 34 2591871
2020-04-13 4 OWNERSHIP DOCUMENT 0001104659-20-045926 5239
2020-03-30 SC 13G SC 13G 0001213900-20-007898 005-50118 20756061 34 110176
2020-03-25 SC 13G SC 13G 0001104659-20-038290 005-50118 20742341 34 56471
2020-03-23 SC 13G PROTALIX BIOTHERAPEUTICS, INC. 0000902664-20-001614 005-50118 20734960 34 77120
2020-03-18 8-K FORM 8-K 8.01,9.01 0001104659-20-035325 001-33357 20724546 34 36047
2020-03-12 10-K FORM 10-K 0001104659-20-032540 001-33357 20709418 34 7830776 1
2020-03-12 8-K 8-K 2.02,9.01 0001104659-20-032178 001-33357 20707250 34 124786
2020-03-12 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-20-032169 001-33357 20707208 34 353683
2020-03-09 SC 13G/A AMENDED SCHEDULE 13G 0001213900-20-005790 005-50118 20698879 34 42385
2020-02-13 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-20-003584 005-50118 20610826 34 35049
2020-02-13 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-20-003571 005-50118 20610619 34 31664
2020-02-10 8-K FORM 8-K 7.01,9.01 0001104659-20-013512 001-33357 20592148 34 43920
2020-02-07 SC 13G/A SC 13G/A 0001140361-20-002573 005-50118 20585947 34 153686
2020-02-06 8-K FORM 8-K 8.01,9.01 0001104659-20-011603 001-33357 20580850 34 36502
2020-02-05 4 OWNERSHIP DOCUMENT 0001104659-20-011315 10568
2020-01-22 4 OWNERSHIP DOCUMENT 0001104659-20-005972 11002
2020-01-22 4 OWNERSHIP DOCUMENT 0001104659-20-005971 11008
2020-01-22 4 OWNERSHIP DOCUMENT 0001104659-20-005970 10807
2020-01-22 4 OWNERSHIP DOCUMENT 0001104659-20-005967 5763
2020-01-22 4 OWNERSHIP DOCUMENT 0001104659-20-005965 5775
2020-01-03 3 OWNERSHIP DOCUMENT 0001104659-20-000974 8609
2020-01-03 3 OWNERSHIP DOCUMENT 0001104659-20-000972 9015
2019-12-20 8-K FORM 8-K 3.03,5.03,9.01 0001104659-19-074602 001-33357 191297613 34 36429
2019-12-19 8-K FORM 8-K 5.02,9.01 0001104659-19-074052 001-33357 191294124 34 34473
2019-12-17 CT ORDER filename1.pdf 20191217,20191217 9999999997-19-007896 001-33357 191289539 34 123547
2019-12-09 8-K FORM 8-K 5.07,8.01,9.01 0001104659-19-070966 001-33357 191275398 34 33578
2019-11-26 DEFA14A DEFA14A 0001104659-19-067679 001-33357 191251964 34 43797
2019-11-18 8-K FORM 8-K 8.01,9.01 0001104659-19-064875 001-33357 191226131 34 44522
2019-11-15 DEFA14A DEFA14A 0001104659-19-064785 001-33357 191225232 34 30771
2019-11-12 DEFA14A DEFA14A 0001104659-19-062654 001-33357 191209992 34 28891
2019-11-07 10-Q FORM 10-Q 0001104659-19-060804 001-33357 191198065 34 3021171 1
2019-11-07 8-K FORM 8-K 2.02,9.01 0001104659-19-060801 001-33357 191198058 34 109872
2019-10-17 8-K FORM 8-K 8.01,9.01 0001104659-19-054507 001-33357 191154065 34 41013
2019-10-15 DEF 14A DEF 14A 0001104659-19-054172 001-33357 191151250 34 1168747
2019-10-04 PRE 14A PRE 14A 0001144204-19-047387 001-33357 191139008 34 952837
2019-09-24 4 OWNERSHIP DOCUMENT 0001144204-19-045806 5788
2019-09-24 3 OWNERSHIP DOCUMENT 0001144204-19-045805 3202
2019-09-24 8-K 8-K 8.01,9.01 0001144204-19-045689 001-33357 191109177 34 44853
2019-08-30 8-K FORM 8-K 3.01,9.01 0001144204-19-043024 001-33357 191069719 34 38049
2019-08-13 8-K FORM 8-K 5.02,9.01 0001144204-19-039539 001-33357 191020772 34 28703
2019-08-08 10-Q FORM 10-Q 0001144204-19-038552 001-33357 191009509 34 2347225 1
2019-08-08 8-K FORM 8-K 2.02,9.01 0001144204-19-038367 001-33357 191007349 34 118866
2019-07-29 8-K 8-K 1.01,5.02,9.01 0001144204-19-036350 001-33357 19979363 34 126125
2019-07-22 8-K FORM 8-K 5.02 0001144204-19-035361 001-33357 19965685 34 20806
2019-07-02 4 OWNERSHIP DOCUMENT 0001144204-19-033654 5759
2019-07-02 3 OWNERSHIP DOCUMENT 0001144204-19-033653 3168
2019-06-17 8-K FORM 8-K 8.01,9.01 0001144204-19-031092 001-33357 19900440 34 36525
2019-06-06 8-K FORM 8-K 8.01,9.01 0001144204-19-029957 001-33357 19881507 34 36263
2019-05-31 8-K FORM 8-K 5.07 0001144204-19-029036 001-33357 19868524 34 30786
2019-05-21 8-K FORM 8-K 1.01,5.02,9.01 0001144204-19-027423 001-33357 19840803 34 126870
2019-05-06 10-Q FORM 10-Q 0001144204-19-023895 001-33357 19799340 34 2077277 1
2019-05-06 8-K FORM 8-K 2.02,9.01 0001144204-19-023738 001-33357 19798046 34 98453
2019-04-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-04-12 16:05:00 9999999995-19-000696 333-230604 19747466 33 1945
2019-04-12 DEF 14A DEFINITIVE PROXY STATEMENT 0001144204-19-019545 001-33357 19746893 34 2222867
2019-04-10 CORRESP filename1.htm 0001144204-19-018975 13162
2019-04-08 UPLOAD filename1.pdf 0000000000-19-006718 40117
2019-03-29 S-3 FORM S-3 0001144204-19-016978 333-230604 19716453 33 1050674
2019-03-18 10-K 10-K 0001144204-19-014464 001-33357 19686984 34 10520392 1
2019-03-18 10-Q/A 10-Q/A 0001144204-19-014455 001-33357 19686803 34 3063204 1
2019-03-18 10-Q/A 10-Q/A 0001144204-19-014453 001-33357 19686796 34 3236083 1
2019-03-18 10-Q/A 10-Q/A 0001144204-19-014450 001-33357 19686792 34 2977879 1
2019-03-18 8-K FORM 8-K 2.02,4.02,9.01 0001144204-19-014447 001-33357 19686780 34 99835
2019-03-15 UPLOAD filename1.pdf 0000000000-19-004851 45857
2019-03-11 CORRESP filename1.htm 0001144204-19-013136 49430
2019-02-14 UPLOAD filename1.pdf 0000000000-19-002296 51621
2019-02-12 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-19-002223 005-50118 19590513 34 78408
2019-02-12 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-19-002214 005-50118 19590200 34 28838
2019-02-08 SC 13G/A SC 13G/A 0001140361-19-002765 005-50118 19579458 34 162249
2019-02-05 8-K FORM 8-K 8.01,9.01 0001144204-19-004918 001-33357 19566182 34 34411
2019-01-10 8-K FORM 8-K 5.07 0001144204-19-001350 001-33357 19520310 34 20678
2019-01-04 8-K FORM 8-K 2.02,7.01,9.01 0001144204-19-000672 001-33357 19510480 34 3496594
2018-12-27 CORRESP filename1.htm 0001144204-18-066309 33369
2018-12-19 DEFA14A DEFA14A 0001144204-18-065270 001-33357 181242189 34 27665
2018-12-17 8-K 8-K 8.01,9.01 0001144204-18-064759 001-33357 181237010 34 32093
2018-12-13 8-K FORM 8-K 5.07 0001144204-18-064451 001-33357 181233586 34 17055
2018-12-04 UPLOAD filename1.pdf 0000000000-18-037154 50707
2018-12-04 CT ORDER filename1.pdf 20181204,20181204 9999999997-18-009272 001-33357 181215692 34 110210
2018-11-07 10-Q FORM 10-Q 0001144204-18-057990 001-33357 181166776 34 2671653 1
2018-11-07 8-K FORM 8-K 2.02,9.01 0001144204-18-057755 001-33357 181164680 34 101862
2018-10-17 DEF 14A DEFINITIVE PROXY STATEMENT 0001144204-18-054229 001-33357 181126668 34 1500485
2018-10-05 PRE 14A PRELIMINARY PROXY STATEMENT 0001144204-18-052765 001-33357 181111281 34 1476479
2018-10-05 8-K FORM 8-K 7.01,9.01 0001144204-18-052605 001-33357 181109269 34 38749
2018-09-21 8-K FORM 8-K 7.01,9.01 0001144204-18-050260 001-33357 181080871 34 35767
2018-09-14 4 OWNERSHIP DOCUMENT 0001144204-18-049524 6253
2018-09-14 4 OWNERSHIP DOCUMENT 0001144204-18-049522 6179
2018-09-14 4 OWNERSHIP DOCUMENT 0001144204-18-049521 6262
2018-09-14 4 OWNERSHIP DOCUMENT 0001144204-18-049517 6026
2018-09-14 4 OWNERSHIP DOCUMENT 0001144204-18-049515 6306
2018-08-13 3 FORM 3 0001144204-18-043724 8297
2018-08-13 8-K FORM 8-K 5.02,9.01 0001144204-18-043714 001-33357 181010246 34 28418
2018-08-09 10-Q FORM 10-Q 0001144204-18-043286 001-33357 181005104 34 2198161 1
2018-08-09 8-K FORM 8-K 2.02,9.01 0001144204-18-042980 001-33357 181003160 34 111045
2018-07-24 8-K 8-K 1.01,8.01,9.01 0001144204-18-039629 001-33357 18966597 34 39323
2018-06-08 3 OWNERSHIP DOCUMENT 0001144204-18-033545 13218
2018-06-08 S-8 FORM S-8 0001144204-18-033540 333-225526 18889516 33 107567
2018-05-31 8-K FORM 8-K 5.02 0001144204-18-031991 001-33357 18871786 34 19739
2018-05-24 8-K FORM 8-K 3.02,8.01,9.01 0001144204-18-030793 001-33357 18857873 34 31682
2018-05-14 8-K FORM 8-K 5.02,5.07 0001144204-18-028177 001-33357 18830578 34 35579
2018-05-09 10-Q FORM 10-Q 0001144204-18-026625 001-33357 18818305 34 1665015 1
2018-05-09 8-K FORM 8-K 2.02,9.01 0001144204-18-026337 001-33357 18816647 34 87051
2018-04-18 DEFA14A DEFA14A 0001144204-18-021154 001-33357 18761260 34 33872
2018-04-16 8-K FORM 8-K 5.07 0001144204-18-020721 001-33357 18756709 34 18644
2018-04-03 CT ORDER filename1.pdf 20180403,20180403 9999999997-18-004151 001-33357 18732867 34 17822
2018-04-02 DEFA14A DEFA14A 0001144204-18-018393 001-33357 18727221 34 2011814
2018-03-23 DEFA14A DEFA14A 0001144204-18-016715 001-33357 18710527 34 18667
2018-03-21 8-K FORM 8-K 7.01,9.01 0001144204-18-016178 001-33357 18704768 34 3125298
2018-03-06 DEF 14A DEFINITIVE PROXY STATEMENT 0001571049-18-000157 001-33357 18669994 34 1304354
2018-03-06 10-K FORM 10-K 0001144204-18-013053 001-33357 18669944 34 7877985 1
2018-03-06 8-K FORM 8-K 2.02,9.01 0001144204-18-012946 001-33357 18668639 34 104088
2018-02-23 PRE 14A PRE 14A 0001144204-18-010571 001-33357 18636987 34 1145332
2018-02-13 SC 13G/A SCHEDULE 13G AMENDMENT 1 0000078003-18-000020 005-50118 18604986 34 40012
2018-02-13 SC 13G/A AMENDMENT TO SCHEDULE 13G 0001213900-18-001658 005-50118 18601701 34 75046
2018-02-12 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-18-001569 005-50118 18594753 34 39345
2018-02-09 SC 13G SC 13G 0001140361-18-006088 005-50118 18590269 34 137663
2018-01-31 8-K 8-K 8.01,9.01 0001144204-18-004740 001-33357 18561022 34 35896
2018-01-25 SC 13G/A SC 13G/A 0001019056-18-000228 005-50118 18548960 34 72219
2018-01-05 8-K FORM 8-K 2.02,9.01 0001144204-18-001057 001-33357 18513482 34 3483034
2017-12-01 8-K FORM 8-K 1.01,9.01 0001144204-17-061920 001-33357 171234279 34 51331
2017-11-27 8-K FORM 8-K 8.01,9.01 0001144204-17-060846 001-33357 171221868 34 36885
2017-11-13 8-K 8-K 8.01,9.01 0001144204-17-057968 001-33357 171193065 34 31568
2017-11-08 10-Q FORM 10-Q 0001144204-17-057290 001-33357 171186844 34 1996546 1
2017-11-08 8-K FORM 8-K 2.02,9.01 0001144204-17-057015 001-33357 171185046 34 114744
2017-10-20 8-K 8-K 5.07 0001144204-17-053341 001-33357 171146006 34 25705
2017-10-19 8-K FORM 8-K 1.01,8.01,9.01 0001144204-17-053226 001-33357 171144853 34 37347
2017-10-10 DEFA14A DEFA14A 0001144204-17-051883 001-33357 171130489 34 627879
2017-09-18 DEFA14A DEFA14A 0001144204-17-048382 001-33357 171088997 34 26692
2017-09-01 DEF 14A DEF 14A 0001144204-17-046387 001-33357 171066395 34 1816882
2017-08-25 DEF 14A DEF 14A 0001144204-17-045196 001-33357 171052331 34 1986012
2017-08-10 PRE 14A PRE 14A 0001144204-17-042072 001-33357 171021877 34 732438
2017-08-09 10-Q 10-Q 0001144204-17-041693 001-33357 171018181 34 2067518 1
2017-08-09 8-K FORM 8-K 2.02,9.01 0001144204-17-041392 001-33357 171016418 34 130051
2017-07-25 8-K FORM 8-K 1.01,2.03,3.02,8.01,9.01 0001144204-17-038121 001-33357 17980950 34 889871 1 1
2017-07-10 SC 13G/A form.htm 0001623632-17-001520 005-50118 17957293 34 276861
2017-06-07 8-K FORM 8-K 8.01,9.01 0001144204-17-031384 001-33357 17895586 34 134083
2017-05-16 4 OWNERSHIP DOCUMENT 0001144204-17-027803 4743
2017-05-10 10-Q FORM 10-Q 0001144204-17-026034 001-33357 17830242 34 1586144 1
2017-05-10 8-K 8-K 2.02,9.01 0001144204-17-025800 001-33357 17828497 34 90088
2017-05-09 8-K FORM 8-K 8.01,9.01 0001144204-17-025419 001-33357 17824447 34 36436
2017-04-18 8-K FORM 8-K 8.01,9.01 0001144204-17-020803 001-33357 17766001 34 25192
2017-04-12 8-K FORM 8-K 5.07,8.01 0001144204-17-020173 001-33357 17758054 34 28410
2017-04-12 8-K FORM 8-K 8.01,9.01 0001144204-17-020074 001-33357 17757010 34 31445
2017-03-29 DEFA14A DEFA14A 0001144204-17-017278 001-33357 17722309 34 26142
2017-03-16 DEF 14A DEF 14A 0001144204-17-015102 001-33357 17694833 34 2444005
2017-03-16 10-K 10-K 0001144204-17-015083 001-33357 17694548 34 6894351 1
2017-03-16 8-K FORM 8-K 2.02,9.01 0001144204-17-014889 001-33357 17692927 34 101189
2017-03-06 PRE 14A PRE 14A 0001144204-17-012961 001-33357 17668054 34 896214
2017-02-23 SC 13G/A SC 13G/A 0001144204-17-010701 005-50118 17633579 34 63326
2017-02-16 8-K FORM 8-K 7.01 0001144204-17-009587 001-33357 17618309 34 16970

Latest XBRL company facts

One latest value per concept from companyfacts (301 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 84.32M 2026-11-01 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
dei EntityPublicFloat Entity Public Float USD 113.10M 2025-06-30 2025 FY 10-K 2026-03-18 0001104659-26-029858
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 735,352 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053016
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 604,485 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053016
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.52M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053016
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.17M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053016
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 95.74 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053016
ffd NetFeeAmt NetFeeAmt USD 1,184.21 2026-08-11 S-8 2026-08-12 0001104659-26-094487
ffd TtlFeeAmt TtlFeeAmt USD 1,184.21 2026-08-11 S-8 2026-08-12 0001104659-26-094487
ffd TtlOfferingAmt TtlOfferingAmt USD 8.57M 2026-08-11 S-8 2026-08-12 0001104659-26-094487
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-11 S-8 2026-08-12 0001104659-26-094487
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 19.58M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001558370-24-015612
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 19.58M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001558370-24-015612
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 4.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 13.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 12.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 655,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 37.05M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 433.15M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 1.31M 2017-01-01 2017-09-30 2018 Q3 10-Q 2019-03-18 0001144204-19-014455
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 1.31M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 43.63M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 895,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 999,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.78M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 3.47M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001558370-21-003681
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.37M 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001558370-25-011471
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001144204-14-015468
us-gaap Assets Assets USD 118.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AssetsCurrent Assets, Current USD 98.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap AssetsNoncurrent Assets, Noncurrent USD 11.98M 2020-09-30 2020 Q3 10-Q 2020-10-29 0001558370-20-011974
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 215,000 2017-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 399,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 22.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -7.45M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-06 0001144204-19-023895
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 22.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 7.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 39.90M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 116,000 2017-01-01 2017-09-30 2018 Q3 10-Q 2019-03-18 0001144204-19-014455
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.36 2020-12-31 2020 FY 10-K 2021-03-30 0001558370-21-003681
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 845,000 2023-05-10 2023 Q3 10-Q 2023-11-06 0001558370-23-017664
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 17.40M 2020-12-31 2020 FY 10-K 2021-03-30 0001558370-21-003681
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 185.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 80.43M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 80.43M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap CommonStockValue Common Stock, Value, Issued USD 80,000 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap ContractWithCustomerAssetNetNoncurrent Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent USD 0 2018-09-30 2018 Q3 10-Q 2019-03-18 0001144204-19-014455
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 10.00M 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress USD 22.15M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001104659-19-060804
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 12.70M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001558370-24-012134
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-02-27 0001558370-23-002102
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 4.50M 2019-10-01 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003039
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 47.30M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132819
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 28.19M 2022-12-31 2023 FY 10-K 2024-03-14 0001558370-24-003161
us-gaap CostOfRevenue Cost of Revenue USD 19.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 4.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 2.00M 2025-03-31 2025 Q1 10-Q 2025-05-09 0001558370-25-007063
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 2.38M 2016-12-01 2016-12-07 2022 FY 10-K 2023-02-27 0001558370-23-002102
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 5.76 2013-09-18 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 69.00M 2013-09-18 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.045 2017-09-30 2017 Q3 10-Q 2017-11-08 0001144204-17-057290
us-gaap DeferredCompensationArrangementWithIndividualRecordedLiability Deferred Compensation Arrangement with Individual, Recorded Liability USD 200,000 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 90,000 2015-09-30 2015 Q3 10-Q 2015-11-09 0001144204-15-063825
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 212,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 837,000 2016-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 61.78M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001144204-18-057990
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3.72M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 1.45M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001144204-18-057990
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.52M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 48.48M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD -372,000 2014-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 352,000 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Severance Payments USD 169,000 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 50.36M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 14.60M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 168,000 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax USD 20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent Assets for Plan Benefits, Defined Benefit Plan USD 578,000 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap Depreciation Depreciation USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 39,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD -189,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax Discontinued Operation, Provision for Loss (Gain) on Disposal, Net of Tax USD -39.90M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 211,000 2017-09-30 2017 Q3 10-Q 2017-11-08 0001144204-17-057290
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent Disposal Group, Including Discontinued Operation, Accounts Payable, Current USD 115,000 2014-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 373,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent Disposal Group, Including Discontinued Operation, Deferred Revenue, Current USD 43.11M 2014-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 25,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss Disposal Group, Including Discontinued Operation, Gross Profit (Loss) USD -164,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap DisposalGroupIncludingDiscontinuedOperationInventoryCurrent Disposal Group, Including Discontinued Operation, Inventory, Current USD 80,000 2015-12-31 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Current USD 1.57M 2015-12-31 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 209,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.39 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001558370-21-011752
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.18 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 1.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.31 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -42,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001558370-23-008132
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 316,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.70M 2021-12-31 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0.14 2016-12-01 2016-12-07 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.561 2016-12-01 2016-12-31 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.02 2016-12-01 2016-12-31 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 3.452 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053016
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 108,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001144204-13-027499
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -192,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001558370-24-003161
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 8.38M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001144204-14-015468
us-gaap GovernmentAssistanceAmountCumulativeNoncurrent GovernmentAssistanceAmountCumulativeNoncurrent USD 3.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap GrossProfit Gross Profit USD 198,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001144204-18-057990
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -18.28M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -4.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 30.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -1.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.18 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.47 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041693
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.47 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041693
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -189,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041693
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041693
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 4.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 4.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 1.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -953,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 105,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 117,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 5.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2019-03-18 0001144204-19-014455
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 34.93M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001144204-18-057990
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 8.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001558370-24-003161
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 236,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-10 0001104659-20-092375
us-gaap IncreaseDecreaseOfRestrictedInvestments Increase (Decrease) of Restricted Investments USD -436,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 131,085 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-07 0001558370-23-013483
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 7.67M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap InterestExpense Interest Expense USD 3.55M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 3.10M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001144204-16-086642
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap InterestPayableCurrent Interest Payable, Current USD 511,000 2023-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003039
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 4.86M 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 20.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap InventoryNet Inventory, Net USD 34.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 2.57M 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 6.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 140,000 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 7.09M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap InventoryWriteDown Inventory Write-down USD 30,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap InvestmentsAndOtherNoncurrentAssets Investments and Other Noncurrent Assets USD 5.03M 2020-06-30 2020 Q2 10-Q 2020-08-10 0001104659-20-092375
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 5.21M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001558370-25-007063
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 27.18M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.00M 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003039
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 933,000 2022-12-31 2022 FY 10-K 2023-02-27 0001558370-23-002102
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.06M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.10M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.19M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.14M 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 18.86M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap Liabilities Liabilities USD 37.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 118.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap LiabilitiesCurrent Liabilities, Current USD 30.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 7.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 1.57M 2015-12-31 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2016-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132819
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 4.56M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 912,000 2014-12-31 2015 Q3 10-Q 2015-11-09 0001144204-15-063825
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -10.96M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041693
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -13.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -1.12M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 15.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -7.74M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 26.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 26.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 26.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 758,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NontradeReceivablesCurrent Nontrade Receivables, Current USD 26,000 2019-12-31 2020 FY 10-K 2021-03-30 0001558370-21-003681
us-gaap NotesIssued1 Notes Issued USD 4.30M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap NotesPayableCurrent Notes Payable, Current USD 4.09M 2020-12-31 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001104659-26-059756
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 29.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 8.32M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 7.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 8.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.40M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-30 0001558370-21-003681
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.134 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 219.80M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.04M 2011-09-30 2011 Q3 10-Q 2011-11-07 0001144204-11-061636
us-gaap OtherIncome Other Income USD 51,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001558370-22-017554
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 51,000 2020-12-31 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap OtherLongTermNotesPayable Other Notes Payable, Noncurrent USD 4.30M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001144204-17-057290
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 6,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001558370-25-007063
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 2.07M 2014-09-30 2014 Q3 10-Q 2014-11-10 0001144204-14-066530
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.80M 2012-02-21 2012-02-22 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap PaymentsToAcquireRestrictedCertificatesOfDeposit Payments to Acquire Restricted Certificates of Deposit USD 42,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent USD 661,000 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap PensionAndOtherPostretirementBenefitContributions Payment for Pension and Other Postretirement Benefits USD 26,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap PensionAndOtherPostretirementBenefitExpense Pension and Other Postretirement Benefits Cost (Reversal of Cost) USD -59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent Liability, Defined Benefit Plan, Noncurrent USD 1.79M 2012-06-30 2012 Q2 10-Q 2012-08-03 0001144204-12-042862
us-gaap PostemploymentBenefitsPeriodExpense Postemployment Benefits, Period Expense USD 1.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 394,000 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap PrepaidRoyalties Prepaid Royalties USD 26,000 2019-12-31 2019 FY 10-K 2020-03-12 0001104659-20-032540
us-gaap ProceedsFromCollaborators Proceeds from Collaborators USD 60.00M 2009-11-01 2009-11-30 2016 FY 10-K 2017-03-16 0001144204-17-015083
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 9.50M 2017-07-01 2017-07-24 2022 FY 10-K 2023-02-27 0001558370-23-002102
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 9.00M 2013-09-01 2013-09-18 2013 FY 10-K 2014-03-13 0001144204-14-015468
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 41.30M 2020-03-18 2022 FY 10-K 2023-02-27 0001558370-23-002102
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -430,000 2020-09-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001558370-20-011974
us-gaap ProceedsFromSaleAndCollectionOfReceivables Proceeds from Sale and Collection of Receivables USD 4.60M 2020-07-01 2020-07-31 2020 Q2 10-Q 2020-08-10 0001104659-20-092375
us-gaap ProceedsFromSaleOfOtherAssets1 Proceeds from Sale of Other Assets USD 3.50M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001144204-14-066530
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2018-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001558370-21-003681
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003039
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 2.69M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001558370-25-007063
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 26.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 41.92M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 5.77M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 2.00M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-09 0001144204-12-027198
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0001558370-24-003161
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 16.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 729,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -385.00M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 50.58M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001104659-19-060804
us-gaap Revenues Revenues USD 75.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5.25 2012-02-22 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 9.09M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap SecurityDeposit Security Deposit USD 513,000 2024-12-31 2024 FY 10-K 2025-03-17 0001558370-25-003039
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 6.02M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001558370-25-007063
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 9.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 1.00M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-28 0001144204-13-012065
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 17,834 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001144204-14-015468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 1.56 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110824
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110824
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.736 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110824
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110824
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 11.34M 2012-06-17 2013 FY 10-K 2014-03-13 0001144204-14-015468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.09M 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 19.70M 2012-12-31 2012 FY 10-K 2013-02-28 0001144204-13-012065
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.59 2020-08-11 2020 Q3 10-Q 2020-10-29 0001558370-20-011974
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 1.91M 2015-03-01 2015-03-23 2017 FY 10-K 2018-03-06 0001144204-18-013053
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.45M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110824
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 5.82M 2014-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 7.47M 2014-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap SharePrice Share Price USD/shares 1.56 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-110824
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 4.6 2021-02-17 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap SharesOutstanding Shares, Outstanding shares 148.38M 2019-03-31 2019 Q1 10-Q 2019-05-06 0001144204-19-023895
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 80.55M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2019-12-09 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap StockIssued1 Stock Issued USD 52,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1.81M 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-06 0001144204-19-023895
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 8.75M 2021-02-17 2023 FY 10-K 2024-03-14 0001558370-24-003161
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 2,501 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132819
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2019-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001558370-22-004823
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 7.78M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.56M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001144204-13-059668
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 8.60M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001144204-15-015672
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 14,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-18 0001144204-19-014464
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 2.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 805,000 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001104659-26-029858
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 145.99M 2018-01-01 2018-06-30 2018 Q2 10-Q 2019-03-18 0001144204-19-014453
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 83.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 42.74M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001558370-21-011752
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 80.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-124771

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →